Literature DB >> 17702979

Targeting interferon-gamma to treat atherosclerosis.

Israel Gotsman, Andrew H Lichtman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17702979     DOI： 10.1161/CIRCRESAHA.107.155838

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

Review 1.  Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.

Authors:  Jacqueline T Vuong; Ashley F Stein-Merlob; Arash Nayeri; Tamer Sallam; Tomas G Neilan; Eric H Yang
Journal:  J Am Coll Cardiol       Date:  2022-02-15       Impact factor: 24.094

2.  Interferon-γ: Promising therapeutic target in atherosclerosis.

Authors:  Joe We Moss; Dipak P Ramji
Journal:  World J Exp Med       Date:  2015-08-20

Review 3.  The role of immune checkpoints in cardiovascular disease.

Authors:  Laura I Yousif; Anniek A Tanja; Rudolf A de Boer; Arco J Teske; Wouter C Meijers
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

Review 4.  Vascular toxic effects of cancer therapies.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-26       Impact factor: 32.419
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.